RALEIGH, N.C.,–(BUSINESS WIRE)–FDA Approval of XEOMIN® (incobotulinumtoxinA) as the First and Only U.S. Neurotoxin for the Simultaneous Treatment of Upper Facial Lines
Home › RSS › Merz Aesthetics Announces FDA Approval of XEOMIN® (incobotulinumtoxinA) as the First and Only U.S. Neurotoxin for the Simultaneous Treatment of Upper Facial Lines